Cancer cells metabolize glucose mainly by glycolysis and are well adapted to metabolic stress. Pim1 is an oncogene that promotes colorectal cancer (CRC) growth and metastasis, and its expression is positively correlated with CRC progression. However, the mechanism underlying Pim1 overexpression during CRC progression and the role of Pim1 in CRC metabolism remains unclear. In the present study, we discovered that Pim1 expression was significantly upregulated in response to glucose deprivation-induced metabolic stress by AMP-activated protein kinase signaling.
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| INTRODUCTION
Metabolic stress often occurs in rapidly proliferating cells that persistently need more energy for survival and growth. [1] [2] [3] Overcoming metabolic stress is certainly a critical step during the growth of solid tumors. A key signaling pathway involved in metabolic adaptation is the LKB1-AMPK pathway. 4 AMPK functions as a critical sensor of cellular energy status and is activated under energy stress conditions. 5 The underlying mechanisms of cell death and survival under metabolic stress are not well understood. In addition, cancer cells have their own ways to adapt to metabolic deprivation. [6] [7] [8] One study reported that nutrient deprivation can induce the Warburg effect, thereby indicating the role of the Warburg effect in helping cancer cells to overcome metabolic stress. 9 Otto Warburg first discovered that even with normal concentrations of oxygen, cancer cells prefer anaerobic breakdown of glucose over mitochondrial oxidative phosphorylation to generate energy, and this phenomenon is known as the "Warburg effect". 10 The Warburg effect is characterized by enhanced glucose uptake and lactate production, representing one of the most important metabolic transformations accompanying tumorigenesis.
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Pim1 is a member of constitutively activated serine/threonine kinases and was first identified as the proviral integration site for Moloney murine leukemia virus, which causes murine leukemia. [11] [12] [13] Pim1 can interact with and phosphorylate several targets that are involved in cell cycle progression or apoptosis. 14 It is overexpressed in many types of cancer cells, including hepatocellular cancer, prostate cancer, glioblastoma, lung cancer, breast cancer and CRC, and its overexpression is associated with tumor development and progression. 13, [15] [16] [17] [18] [19] In colon cancer, Pim1 repression leads to major changes in oncogenic signal transduction with regard to p21
Cip1/WAF1
, STAT3, JNK, c-Myc, and survivin and in the levels of apoptosis-related proteins Puma, Bax, and Bcl-xL. 19 However, the underlying mechanism of Pim1 in CRC remains unclear.
In the present study, we aimed to address some key questions regarding the expression pattern of Pim1 in CRC. 
| Antibodies and reagents
The following antibodies were used in this study: anti-Pim1 
| Statistical analysis
The 
| Pim1 is upregulated in CRC tissues
First, we conducted IHC analysis in 296 patients with CRC to determine whether Pim1 expression was altered in cancer tissues. As shown in Figure 1A , Pim1 immunoreactivity was observed in both the nucleus and the cytoplasm of tumor cells. (Figure 2A,B) . AMPK is known as an intracellular energy sensor, and the Thr172 phosphorylated form of AMPK indicates the severity of glucose restriction. 3 Our results
showed that phosphorylated AMPK and Pim1 protein expression correspondingly increased in CRC cells ( Figure 2B ), suggesting that AMPK may act as a mediator of the response of Pim1 under glucose deprivation conditions. In addition, treatment of A769662 (an AMPK activator) induced Pim1 expression ( Figure 2C ), whereas AMPK inactivation by compound C (an AMPK inhibitor) treatment significantly attenuated glucose deprivation-induced Pim1 expression ( Figure 2D ). Taken together, these findings suggest that Pim1 is a gene that responds to glucose deprivation at least partly through the AMPK pathway. Figure 4C ). Ki-67 index was also lower in the Pim1 knockdown groups than in the control groups (Figure 4D) . Therefore, Pim1 promotes CRC tumorigenesis both in vitro and in vivo.
| Determination of the efficiency of Pim1 overexpression and knockdown

| Altered Pim1 expression affects the Warburg effect in CRC cells
Next, we attempted to verify whether Pim1 promotes the Warburg effect in CRC cells. Pim1 knockdown decreased glucose uptake and lactate production in cells, whereas Pim1 overexpression markedly increased these phenomena ( Figure 5A,C) . In addition, mRNA (Fig- ure 5B,D) and protein ( Figure 5E ,F) levels of HK2 and LDHA, which 
| DISCUSSION
Metabolic stress is considered a common impediment to tumor growth; however, it remains unclear how cancer cells overcome metabolic stress to keep growing. 3 Our study showed that Pim1 was upregulated by AMPK signaling in response to glucose deprivation, indicating that Pim1 acts as an oncogene that is responsive to glu- Oncogenic PIM1 is a constitutively active serine-threonine kinase.
Pim1 can promote cell cycle progression by phosphorylating CDC25A, CDC25C, p21cip1, p27kip1, and c-TAK1. 14, [25] [26] [27] [28] In addition to its essential roles in the cell cycle, Pim1 is involved in proliferation, migration, apoptosis, cell death, tumor growth, and chemotherapy response in cancer cells. 16, 29, 30 Pim1 is overexpressed in many types of cancer cells, including hepatocellular cancer, prostate cancer, glioblastoma, lung cancer, breast cancer and CRC, and its overexpression is associated with tumor development and progression. 13, [15] [16] [17] [18] [19] In the present study, we used CRC TMA containing 296 CRC patient samples and 72 fresh CRC samples. Based on our results, Pim1 was overexpressed in CRC tissues relative to that in adjacent normal tissues, and Pim1 overexpression was correlated with tumor size and invasion depth. Despite the critical role of Pim1 in cancer development F I G U R E 5 Pim1 facilitates the Warburg effect in colorectal cancer cells. A, Glucose uptake and lactate production in indicated cells 24 h after transfection (*P < .05). B, Knockdown of Pim1 decreased hexokinase 2 (HK2) and lactate dehydrogenase A (LDHA) mRNA levels (*P < .05). C, Pim1 overexpression facilitated the Warburg effect in HT29 cells and (D) increased HK2 and LDHA mRNA levels (*P < .05). E, Knockdown of Pim1 decreased HK2 and LDHA protein levels. F, Pim1 overexpression increased HK2 and LDHA protein levels. G, Pim1 H score based on immunohistochemistry was positively correlated with maximum standard uptake value (SUVmax). H, Relationship of Pim1 with HK2 and LDHA was analyzed using GEPIA (http://gepia.cancer-pku.cn/). Sc, scramble and progression, there is little evidence regarding the function of Pim1 in cancer metabolism, especially in CRC.
Cancer metabolism is an important link between the tumor microenvironment and tumor progression. 31 | 1477 transporters and enzymes in the glycolytic pathway resulting from oncogene activation. 23, 33 In the present study, we found that altered Pim1 expression influenced glucose consumption and lactate production by regulating the expression of HK2 and LDHA. In addition, Pim1 expression was positively correlated with HK2 and LDHA expression in CRC tissues.
It is well established that Pim1 is closely linked with c-myc. Jongchan Kim et alreported that Pim1 promotes tumorigenicity at least in part by enhancing c-MYC transcriptional activity in prostate cancer. 34 Coexpression of both Pim1 and c-myc has been observed in prostate cancer and triple-negative breast cancer. 14, 35 The first identified glucose metabolism-associated gene that is directly regulated by c-myc is LDHA, 36, 37 and the subsequently identified genes are GLUT1 and HK2. 38, 39 Knockdown of Pim1 has also been reported to reduce glycolysis in hepatocellular carcinoma by targeting the PI3K/ AKT pathway. 13 These findings highlight the possible role of Pim1 in cancer metabolism.
In summary, for the first time, the present study provided critical insights into the role of Pim1 in CRC metabolism. Pim1 was upregu- 
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